Skip to main content

Table 1 hHSIL+ among 764 women with and without biopsies respectively, by combination of cytology, VIA, PCR and careHPV results

From: Evaluation of human-papillomavirus testing and visual inspection for cervical cancer screening in Rwanda

Cytology1

VIA2

PCR3

careHPV

N

Women with biopsy

Women without biopsy

All women

N

Confirmed

N

Estimated

hHSIL+

%

hHSIL+

hHSIL+

<cHSIL

ā€“

ā€“

ā€“

587

6

0

581

0.0

0.0

0.0

ā€“

ā€“

+

28

20

1

8

0.4

1.4

5.0

ā€“

+

ā€“

42

28

1

14

0.5

1.5

3.6

ā€“

+

+

51

41

2

10

0.5

2.5

4.9

+

ā€“

ā€“

27

24

0

3

0.0

0.0

0.0

+

ā€“

+

2

1

0

1

0.0

0.0

0.0

+

+

ā€“

3

2

1

1

0.5

1.5

50.0

+

+

+

4

3

2

1

0.7

2.7

66.7

cHSIL+

ā€“

+

ā€“

3

2

2

1

} 1.3

} 4.3

}25.0

ā€“

+

+

14

10

1

4

+

+

+

3

2

2

1

1.0

3.0

100.0

Ā 

764

139

12

625

5

17

2.2

  1. 1 19 missing cytology are considered cytology negative
  2. 2 Screening VIA at first visit
  3. 3 HR-HPV positivity for GP5+/6+-based PCR testing
  4. cHSIL cytological high-grade squamous intraepithelial lesions, hHSIL histological high-grade squamous intraepithelial lesions, HR-HPV high-risk human papillomavirus, PCR polymerase chain reaction, VIA visual inspection with acetic acid